Pfizer nixes more study of twice-daily obesity pill treatment that made many patients nauseous
FILE - The Pfizer logo is displayed at the company's headquarters, Friday, Feb. 5, 2021, in New York. Pfizer shares sank Friday, Dec. 1, 2023, when the drugmaker announced that it was abandoning a twice-daily obesity treatment after more than half the patients in a clinical trial stopped taking…#pfizer #apphoto #marklennihan #novonordisk #elililly #novo #obese #elilillys #mikaeldolsten #danuglipron
Source: Reuters: Health - Category: Consumer Health News Source Type: news
More News: Clinical Trials | Eating Disorders & Weight Management | Health | Obesity | Pfizer | Study